American Ginseng for Blood Sugar Regulation

Research suggests that American ginseng and its active compounds, particularly ginsenosides, may support blood sugar regulation and broader metabolic function through several biological mechanisms, including improvements in insulin sensitivity, glucose uptake, lipid metabolism, and key cellular signaling pathways involved in glucose processing. Studies indicate that these effects may operate through multiple routes, with one study identifying a previously unrecognized connection between ginsenoside Rb1 and riboflavin metabolism as a possible contributor to post-meal blood sugar control, while others point to AMPK and insulin receptor signaling as relevant pathways. All five studies reviewed were conducted in animal or cell-based models — including mice, rats, zebrafish larvae, and insulin-resistant liver cells — and none involved human clinical trials, which is a significant limitation when drawing conclusions about real-world applicability. The findings across these studies are consistently supportive in direction, but the absence of human research means the evidence, while mechanistically suggestive, remains preliminary and cannot yet be used to draw firm conclusions about effectiveness or safety in people.